| abstract |
The present invention shows that R 3 represents an aromatic 5- or 6-membered heteroaromatic ring, which can optionally be fused to phenyl, wherein the heterocycle or fused heterocycle is optionally substituted. And X represents carboxylic acid, ester or amide or sulfonamide, and the anilinopyrazole compound of formula (I), wherein the remaining groups are as defined herein. The invention also relates to pharmaceutical compositions containing these materials and methods for treating diabetes and related disorders using these materials. |